Medicines Distribution Consent




NEW ZEALAND GAZETTE, No. 105

23 JULY 2009


Product:
DBL® Oxaliplatin for injection

Active Ingredient:
Oxaliplatin 100mg

Dosage Form:
Powder for injection

New Zealand Sponsor:
Hospira NZ Limited

Manufacturer:
Hospira Australia Pty Limited, Mulgrave, Victoria, Australia


Product:
Dimetapp Daytime/Nightime Liquid Caps

Daytime

Active Ingredients:
Dextromethorphan hydrobromide monohydrate 10mg
Paracetamol 300mg

Dosage Form:
Capsule

Nightime

Active Ingredients:
Dextromethorphan hydrobromide monohydrate 10mg
Doxylamine succinate 6.25mg
Paracetamol 300mg

Dosage Form:
Capsule

New Zealand Sponsor:
Wyeth Consumer Healthcare a Division of Wyeth (NZ) Limited

Manufacturer:
Catalent Australia Pty Limited, Braeside, Victoria, Australia


Product:
Dimetapp Nightime Cold & Flu Liquid Caps

Active Ingredients:
Dextromethorphan hydrobromide monohydrate 10mg
Doxylamine succinate 6.25mg
Paracetamol 300mg

Dosage Form:
Liquid filled capsule

New Zealand Sponsor:
Wyeth Consumer Healthcare a Division of Wyeth (NZ) Limited

Manufacturer:
Catalent Australia Pty Limited, Braeside, Victoria, Australia


Product:
Irinotecan

Active Ingredient:
Irinotecan hydrochloride trihydrate 20mg/mL equivalent to irinotecan 17.33mg

Dosage Form:
Concentrate for infusion

New Zealand Sponsor:
Mylan New Zealand Limited

Manufacturer:
GP-Pharm, S.A., Polígono Industrial Els Vinyets-Els Fogars, Barcelona, Spain


Product:
Lopresor

Active Ingredient:
Metoprolol tartrate 5mg

Dosage Form:
Solution for injection

New Zealand Sponsor:
Novartis New Zealand Limited

Manufacturer:
Novartis Stein AG, Stein, Switzerland


Product:
Vigamox

Active Ingredient:
Moxifloxacin hydrochloride 0.545%w/v equivalent to moxifloxacin 0.5%w/v

Dosage Form:
Eye drops, solution

New Zealand Sponsor:
Alcon New Zealand Limited

Manufacturer:
Alcon Laboratories Inc, Fort Worth, Texas, United States of America

Dated this 20th day of July 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go6204


Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product:
Head & Shoulders Anti-Dandruff Shampoo for Men Hair Retain

Active Ingredient:
Pyrithione zinc 1%w/w

Dosage Form:
Shampoo

New Zealand Sponsor:
Procter & Gamble Distributing New Zealand

Manufacturer:
Procter & Gamble Manufacturing (Thailand) Limited, Bangsmark, Bangkpakong, Chacheonsao, Thailand

Dated this 20th day of July 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go6205



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 105





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
20 July 2009
Medicines, Consent, Distribution, Medicines Act 1981, Hospira NZ Limited, Wyeth Consumer Healthcare, Mylan New Zealand Limited, Novartis New Zealand Limited, Alcon New Zealand Limited, Oxaliplatin, Dimetapp, Irinotecan, Lopresor, Vigamox
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

🏥 Consent to the Distribution of a New Related Product

🏥 Health & Social Welfare
20 July 2009
Medicines, Consent, Distribution, Medicines Act 1981, Procter & Gamble Distributing New Zealand, Head & Shoulders Anti-Dandruff Shampoo for Men Hair Retain
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health